CiglitazoneAlternative Names: ADD 3878; U 63287
Latest Information Update: 24 Nov 1994
At a glance
- Originator Takeda
- Class Antihyperglycaemics; Antihypertensives; Small molecules; Thiazolidinediones
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 24 Nov 1994 Discontinued-II for Diabetes mellitus in Japan (PO)